SEC Form 4 · accession 0001127602-18-032958
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence Baldini
Officer — EVP, Global Operations
Period of report
Nov 12, 2018
Accepted (ET)
Nov 14, 2018 · 9:52 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 12, 2018 | S | 25,225 | $19.3531 | D | 76,129 | D | |
| Common StockF2 | Nov 13, 2018 | S | 9,876 | $19.5471 | D | 66,253 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Prices range from $19.35 per share to $19.42 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
- F2Prices range from $19.40 per share to $19.82 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.